• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

228
28
25
24
10

COUNTRY

24
4
3
2
1

CATEGORIES

  • 127
  • 71
  • 53
  • 46
  • 30
  • 25
  • 23
  • 23
  • 18
  • 7
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

129
205
285
442

PUBLISHED

6
26
68
442

PRODUCT TYPE

392
43
7

Search "Company Analysis - Forest Laboratories, Inc." returned 442 results.

PRODUCT TITLE
Forest Laboratories Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis Forest Laboratories Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis - Product Thumbnail Image

Forest Laboratories Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Forest Laboratories Inc. Company Profile” is a comprehensive report on Forest Laboratories Inc.. The report provides complete information on the operations, organization structure and financial information...

October 2013
FROM
Forest Laboratories, Inc.: Company Profile and SWOT Analysis Forest Laboratories, Inc.: Company Profile and SWOT Analysis - Product Thumbnail Image

Forest Laboratories, Inc.: Company Profile and SWOT Analysis

Synopsis ICD Research's "Forest Laboratories, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview,...

December 2011
FROM
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Forest Laboratories, Inc. (FRX) : Company Profile and SWOT Analysis

Synopsis 'Forest Laboratories, Inc. (FRX) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview,...

June 2012
FROM
FRX - Forest Laboratories Inc - Company Analysis and ASR Ranking Report FRX - Forest Laboratories Inc - Company Analysis and ASR Ranking Report - Product Thumbnail Image

FRX - Forest Laboratories Inc - Company Analysis and ASR Ranking Report

Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician's prescription. The Company also manufactures non-prescription...

March 2013
FROM
Forest Laboratories, Inc.: SWOT Analysis & Company Profile Forest Laboratories, Inc.: SWOT Analysis & Company Profile - Product Thumbnail Image

Forest Laboratories, Inc.: SWOT Analysis & Company Profile

Synopsis Business Review’s Forest Laboratories, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT...

November 2010
FROM
Forest Laboratories Inc,(FRX) Profile and Financials, plus Engineering & Research Industry Trends Analysis, Operating Ratio and Financial Averages Forest Laboratories Inc,(FRX) Profile and Financials, plus Engineering & Research Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Forest Laboratories Inc,(FRX) Profile and Financials, plus Engineering & Research Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis plus vital industry benchmarks and extensive operating ratios, along with an analysis of key industry trends....

July 2014
FROM
Forest Laboratories Inc,(FRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Forest Laboratories Inc,(FRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Forest Laboratories Inc,(FRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Forest Laboratories Inc (FRX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Forest Laboratories Inc,(FRX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages Forest Laboratories Inc,(FRX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Forest Laboratories Inc,(FRX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Forest Laboratories Inc (FRX), plus vital industry benchmarks and extensive operating ratios, along with...

December 2012
FROM
Forest Laboratories, Inc. - Product Pipeline Review - 2012 Forest Laboratories, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Forest Laboratories, Inc. - Product Pipeline Review - 2012

Forest Laboratories, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Forest Laboratories, Inc. - Product Pipeline Review - 2012” provides data on the...

November 2012
FROM
Forest Laboratories, Inc. - Product Pipeline Review - 2013 Forest Laboratories, Inc. - Product Pipeline Review - 2013 - Product Thumbnail Image

Forest Laboratories, Inc. - Product Pipeline Review - 2013

Forest Laboratories, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Forest Laboratories, Inc. - Product Pipeline Review - 2013” provides data on the...

April 2013
FROM

Forest Laboratories, Inc. - SWOT, Strategy and Corporate Finance Report

Forest Laboratories, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis,...

April 2013
FROM

Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review

Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2014
FROM

Forest Laboratories, Inc. - Strategy and SWOT Report

Forest Laboratories, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

February 2014
FROM

Forest Laboratories, Inc. - Product Pipeline Review - Q4 2010

Forest Laboratories, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Forest Laboratories, Inc. - Product Pipeline Review - Q4 2010” provides data on...

December 2010
FROM
Analysis of Forest Laboratories Analysis of Forest Laboratories - Product Thumbnail Image

Analysis of Forest Laboratories

Analysis of Forest Laboratories. A complete and comprehensive analysis of Forest Laboratories, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry,...

January 2013
FROM

Forest Laboratories, Inc. - Product Pipeline Review - 2014

Forest Laboratories, Inc. - Product Pipeline Review - 2014 Summary This, ‘Forest Laboratories, Inc. - Product Pipeline Review - 2014’, provides an overview of the Forest Laboratories, Inc.’s pharmaceutical...

July 2014
FROM
Fibromyalgia Therapeutics - Global Strategic Business Report Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Fibromyalgia Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Europe, and Rest of World Annual estimates and...

July 2012
FROM

Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016

TechNavio's analysts forecast the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market to grow at a CAGR of 3 percent over the period 2012-2016 One of the key factors contributing...

May 2013
FROM

Global Alzheimer's Drugs Market 2012-2016

The analysts forecast the Global Alzheimer's Drugs market to grow at a CAGR of 3 26 percent over the period 2012-2016 One of the key factors contributing to this market growth is the increasing aging...

May 2013
FROM
Loading Indicator